Showing results (521-530 of 1,303) with videos related to
Sort By:
Pageof 131
Journal of Gynecologic Oncology|July 23, 2019
Prior uterine myoma and risk of ovarian cancer: a population-based case-control studyJenn Jhy Tseng, Chun Che Huang, Hsiu Yin Chiang, et al.Journal of Gynecologic Oncology|July 23, 2019
Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 stepsMellie Heinemann, Isabelle Masquin, Guillaume Blache, et al.Journal of Gynecologic Oncology|July 23, 2019
The efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervixNopporn Rodpenpear, Kamol PataradoolJournal of Gynecologic Oncology|July 23, 2019
PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progressionPeey Sei Kok, Philip Beale, Rachel L O'Connell, et al.Journal of Gynecologic Oncology|January 25, 2014
Cervical preneoplasia biomarkers: a conundrum for the community based gynecologic surgical pathologistLouis-Jacques van BogaertJournal of Gynecologic Oncology|January 25, 2014
Reproductive outcomes after laparoscopic radical trachelectomy for early-stage cervical cancerJeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, et al.Journal of Gynecologic Oncology|January 25, 2014
FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtypeUlla-Maija Haltia, Ralf Bützow, Arto Leminen, et al.Journal of Gynecologic Oncology|January 25, 2014
A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancerAn Jen Chiang, Jiabin Chen, Yu-Che Chung, et al.Journal of Gynecologic Oncology|October 25, 2012
Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancerTae Wook Kong, Suk-Joon Chang, Jiheum Paek, et al.Journal of Gynecologic Oncology|October 25, 2012
Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in KoreaHeon Jong Yoo, Myong Cheol Lim, Sang-Soo Seo, et al.Pageof 131